| Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium. | None |
| Strong HER-2/neu protein overexpression by immunohistochemistry often does not predict oncogene amplification by fluorescence in situ hybridization. | None |
| The role of HER-2/neu oncogene and vimentin filaments in the production of the Paget s phenotype. | None |
| Deregulated expression of interferon regulatory factor-1 in oncogene-transformed mouse fibroblasts. | None |
| Upregulation of the Catalytic Telomerase Subunit by the Transcription Factor ER81 and Oncogenic HER2/Neu, Ras, or Raf. | None |
| Immunobiology of HER-2/neu oncoprotein and its potential application in cancer immunotherapy. | None |
| HER-2 oncogene expression is regulated by COX-2 and prostaglandin E2. | None |
| High Nup88 mRNA expression levels correlated with ductal and tubular histology, nuclear grade 3, absence of hormone receptors, expression of c-erb-B2 oncogene and mutant p53 protein, high proliferation, DNA aneuploidy, and axillary node invasion. | None |
| analysis of the proto-oncogenic and mutant forms of the transmembrane region of Neu in micelles | None |
| Germ-line expression of an oncogenic erbB2 allele confers resistance to erbB2-induced mammary tumorigenesis. | None |
| Increased serum maternal levels of the HER2 oncoprotein p105 ectodomain in preeclampsia. | None |
| Overexpression of HER2/neu oncoprotein in cytologic specimens. | None |
| Generation of Peptide mimics of the epitope recognized by trastuzumab on the oncogenic protein Her-2/neu. | None |
| Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells. | None |
| Interlaboratory comparison of HER-2 oncogene amplification as detected by chromogenic and fluorescence in situ hybridization. | None |
| p185HER2 overexpression and HER2 oncogene amplification in recurrent vulvar Paget s disease. | None |
| Tumor suppressor ARF inhibits HER-2/neu-mediated oncogenic growth. | None |
| Expression of epidermal growth factor receptor and c-erbB-2 oncoprotein in trophoblast populations of placenta accreta. | None |
| Amplification of EGFR was found in 10.37% of cases. The analysis revealed a lack of correlation between amplification of the oncogenes and the tumor phenotype. | None |
| Tissue microarray analysis of EGFR and HER2 oncogene copy number alterations in squamous cell carcinoma of the larynx. | None |